Semaglutide medication may benefit 93 million U.S. adults — ScienceDaily
Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy. They projected based on the known weight loss effects (15% average weight …